Works matching IS 10600280 AND DT 2022 AND VI 56 AND IP 1
Results: 16
Call to Pharmacists: End Use of "Red Man Syndrome".
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 102, doi. 10.1177/10600280211021417
- By:
- Publication type:
- Article
Comment: Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of Bacteroides fragilis to Antibiotics.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Response to Comment on "Expectation for Prediction Models for Prothrombin Time International Normalized Ratio Under Warfarinization for Safety Use in the Era of Precision Medicine".
- Published in:
- 2022
- By:
- Publication type:
- Letter
The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 5, doi. 10.1177/10600280211017315
- By:
- Publication type:
- Article
Zonisamide Use With Continuous Renal Replacement Therapy.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Deferasirox-Induced Hyperammonemia in an Adult Patient After Allogeneic Stem Cell Transplantation.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Impact of Opioid Administration in the Intensive Care Unit and Subsequent Use in Opioid-Naïve Patients.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 52, doi. 10.1177/10600280211016856
- By:
- Publication type:
- Article
Deviant Dosing: A Post hoc Analysis of Pharmacist Characteristics Related to Renal Dosing Decisions.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 65, doi. 10.1177/10600280211016328
- By:
- Publication type:
- Article
Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 93, doi. 10.1177/10600280211015987
- By:
- Publication type:
- Article
Assessment and Impact of Intravenous Medication Fluid Administration in Critically Ill Patients With Acute Respiratory Failure.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 35, doi. 10.1177/10600280211013581
- By:
- Publication type:
- Article
Effect of PARP Inhibitors as Maintenance Treatment on Restricted Mean Survival Time in Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review and Meta-analysis.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 27, doi. 10.1177/10600280211013489
- By:
- Publication type:
- Article
Antibody-Mediated Rejection Management Following Lung Transplantation.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 60, doi. 10.1177/10600280211012410
- By:
- Publication type:
- Article
Approach to Sedation and Analgesia in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 73, doi. 10.1177/10600280211010751
- By:
- Publication type:
- Article
Impact of Removing the Race Coefficient in Renal Function Estimate Equations on Drug Dosage Recommendations.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 44, doi. 10.1177/10600280211010228
- By:
- Publication type:
- Article
The Safety and Efficacy Evaluation of Dexmedetomidine for Procedural Sedation and Postoperative Behaviors in Pediatric Populations: A Systematic Review and Meta-analysis.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 16, doi. 10.1177/10600280211009845
- By:
- Publication type:
- Article
Usefulness of the Biomarker TIMP-2•IGFBP7 for Acute Kidney Injury Assessment in Critically Ill Patients: A Narrative Review.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 1, p. 83, doi. 10.1177/10600280211005425
- By:
- Publication type:
- Article